CRISAFULLI, GIOVANNI
 Distribuzione geografica
Continente #
NA - Nord America 3.141
EU - Europa 2.720
AS - Asia 1.923
OC - Oceania 62
SA - Sud America 38
AF - Africa 15
Continente sconosciuto - Info sul continente non disponibili 6
Totale 7.905
Nazione #
US - Stati Uniti d'America 3.045
IT - Italia 1.201
CN - Cina 1.193
GB - Regno Unito 251
DE - Germania 228
FR - Francia 208
JP - Giappone 206
IE - Irlanda 123
SE - Svezia 123
HK - Hong Kong 106
ES - Italia 94
IN - India 86
SG - Singapore 78
CA - Canada 74
FI - Finlandia 69
KR - Corea 61
TW - Taiwan 51
BE - Belgio 46
NL - Olanda 44
AU - Australia 43
PL - Polonia 41
UA - Ucraina 41
AT - Austria 36
DK - Danimarca 31
GR - Grecia 28
IL - Israele 28
CH - Svizzera 27
VN - Vietnam 23
HU - Ungheria 20
MX - Messico 20
NO - Norvegia 20
BR - Brasile 19
CZ - Repubblica Ceca 19
NZ - Nuova Zelanda 19
PT - Portogallo 17
TR - Turchia 15
RO - Romania 14
RU - Federazione Russa 12
IR - Iran 11
TH - Thailandia 11
AR - Argentina 10
MY - Malesia 10
AM - Armenia 8
BA - Bosnia-Erzegovina 8
HR - Croazia 6
ID - Indonesia 6
EG - Egitto 5
ZA - Sudafrica 5
AE - Emirati Arabi Uniti 4
BN - Brunei Darussalam 4
KZ - Kazakistan 4
RS - Serbia 4
CL - Cile 3
CO - Colombia 3
CY - Cipro 3
PK - Pakistan 3
SA - Arabia Saudita 3
AP - ???statistics.table.value.countryCode.AP??? 2
DZ - Algeria 2
EU - Europa 2
JO - Giordania 2
KW - Kuwait 2
LB - Libano 2
LT - Lituania 2
LU - Lussemburgo 2
PE - Perù 2
SN - Senegal 2
A1 - Anonimo 1
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
BD - Bangladesh 1
BG - Bulgaria 1
BY - Bielorussia 1
HN - Honduras 1
LK - Sri Lanka 1
PR - Porto Rico 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
TZ - Tanzania 1
UZ - Uzbekistan 1
VE - Venezuela 1
Totale 7.905
Città #
Ann Arbor 427
Chandler 275
Beijing 213
Shanghai 172
Redwood City 146
Houston 128
Guangzhou 126
Torino 126
Milan 123
Fairfield 121
Dublin 112
Turin 100
Ashburn 93
Cambridge 86
Woodbridge 79
Seattle 78
New York 70
Tokyo 66
Wilmington 66
Dearborn 61
Nyköping 46
Rome 46
Boston 44
Nanjing 44
Hangzhou 42
Wuhan 41
Singapore 38
Lappeenranta 36
Pisa 36
Villeurbanne 34
Vienna 31
Carrara 29
Genoa 29
London 29
Medford 27
Paris 26
Brussels 25
Los Angeles 25
Taipei 25
Berlin 23
Central 23
Princeton 23
San Diego 23
Barcelona 22
Boardman 22
Jacksonville 22
Munich 22
Central District 20
Fremont 20
Warsaw 20
Luni 19
Bologna 18
San Francisco 18
Jinan 17
Chicago 16
Duncan 16
Shenyang 16
Toulouse 16
Buffalo 15
Helsinki 15
Ottawa 15
Redmond 15
San Mateo 15
Tianjin 15
Toronto 15
Changsha 14
Chengdu 14
Norwalk 14
Rochester 14
Chongqing 13
Pittsburgh 13
Xian 13
Dallas 12
Hong Kong 12
Phoenix 12
Seoul 12
Somerville 11
Budapest 10
Dong Ket 10
Grafing 10
Lyngby 10
Melbourne 10
Rehovot 10
Shenzhen 10
Zhengzhou 10
Baltimore 9
Birmingham 9
Dunedin 9
Fuzhou 9
Madrid 9
Mainz 9
Nanchang 9
Oslo 9
Palermo 9
Silver Spring 9
Simi Valley 9
Valencia 9
Washington 9
Bengaluru 8
Chennai 8
Totale 4.169
Nome #
Inactivation of DNA repair triggers neoantigen generation and impairs tumour growth 1.752
Adaptive mutability of colorectal cancers in response to targeted therapies 1.683
Tracking a CAD-ALK gene rearrangement in urine and blood of a colorectal cancer patient treated with an ALK inhibitor 690
A Genomic Analysis Workflow for Colorectal Cancer Precision Oncology 547
Emergence of multiple EGFR extracellular mutations during cetuximab treatment in colorectal cancer 426
Clonal evolution and resistance to EGFR blockade in the blood of colorectal cancer patients 363
Acquired RAS or EGFR mutations and duration of response to EGFR blockade in colorectal cancer 280
Loss of AXIN1 drives acquired resistance to WNT pathway blockade in colorectal cancer cells carrying RSPO3 fusions 235
Genetic Evolution of Glioblastoma Stem-Like Cells From Primary to Recurrent Tumor 227
Temozolomide treatment alters mismatch repair and boosts mutational burden in tumor and blood of colorectal cancer patients 210
Molecular landscape of acquired resistance to targeted therapy combinations in BRAF mutant colorectal cancer 191
Acquired resistance to the TRK inhibitor entrectinib in colorectal cancer 180
Genotyping tumour DNA in cerebrospinal fluid and plasma of a HER2-positive breast cancer patient with brain metastases 172
Emergence of MET hyper-amplification at progression to MET and BRAF inhibition in colorectal cancer 158
Tracking colorectal cancer evolution in time and space 150
Radiologic and Genomic Evolution of Individual Metastases during HER2 Blockade in Colorectal Cancer 144
DNA damage response and repair genes in advanced bone and soft tissue sarcomas: An 8-gene signature as a candidate predictive biomarker of response to trabectedin and olaparib combination 83
Werner helicase is a synthetic-lethal vulnerability in Mismatch Repair-Deficient Colorectal Cancer Refractory to Targeted Therapies, Chemotherapy and Immunotherapy 80
Tumor heterogeneity and Lesion-Specific response to targeted therapy in colorectal cancer 75
Temozolomide drives mismatch repair deficiency and fosters neoantigen generation in tumor cells 63
Graves' disease prevalence in a young population with Turner syndrome 61
Liquid biopsies to monitor and direct cancer treatment in colorectal cancer 55
Circulating tumor DNA to guide rechallenge with panitumumab in metastatic colorectal cancer: the phase 2 CHRONOS trial 51
Parp1 inhibitor and trabectedin combination does not increase tumor mutational burden in advanced sarcomas—a preclinical and translational study 50
Whole exome sequencing analysis of urine trans-renal tumour DNA in metastatic colorectal cancer patients 43
Coexisting cancer stem cells with heterogeneous gene amplifications, transcriptional profiles, and malignancy are isolated from single glioblastomas 37
A modified fluctuation-test framework characterizes the population dynamics and mutation rate of colorectal cancer persister cells 37
Liquid biopsy of cerebrospinal fluid enables selective profiling of glioma molecular subtypes at first clinical presentation 14
Case report: Preclinical efficacy of NEDD8 and proteasome inhibitors in patient-derived models of signet ring high-grade mucinous colorectal cancer from a Lynch syndrome patient 14
Transcriptome-wide gene expression outlier analysis pinpoints therapeutic vulnerabilities in colorectal cancer 6
Abstract LB058: A transcriptome-wide gene expression outlier analysis pinpoints therapeutic vulnerabilities in colorectal cancer 5
Circulating Tumor DNA to Drive Treatment in Metastatic Colorectal Cancer 4
Abstract A120: Adaptive mutability of colorectal cancers in response to targeted therapies 4
Abstract 3588: Emergence of multiple EGFR extracellular mutations during cetuximab treatment in colorectal cancer 2
Totale 8.092
Categoria #
all - tutte 16.229
article - articoli 0
book - libri 0
conference - conferenze 347
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 16.576


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020748 50 25 40 68 51 67 59 61 98 103 84 42
2020/20211.420 50 69 81 141 134 120 145 94 126 164 131 165
2021/20221.686 184 167 155 221 85 102 120 112 124 99 178 139
2022/20231.650 109 122 123 155 121 196 122 164 181 89 147 121
2023/20241.449 118 132 126 110 110 134 134 110 38 143 143 151
2024/202553 53 0 0 0 0 0 0 0 0 0 0 0
Totale 8.092